Related by context. All words. (Click for frequent words.) 78 Anti Tumor 75 Kinase Inhibitor 75 Antiangiogenic 74 Prolongs Survival 74 Immunomodulatory 73 Anticancer Drug 73 Small Molecule 73 Kinase Inhibitors 73 Anti Tumor Activity 73 Initiates Clinical 72 Cytotoxic 72 Tyrosine Kinase Inhibitor 72 Meets Primary Endpoint 72 Novel Therapeutic 72 Drug Candidate 72 Presents Preclinical Data 72 Therapeutic Antibody 72 Novel Mechanism 72 RNAi Therapeutic 71 Systemic Delivery 71 Immunotherapeutic 71 Clinical Trial Results 71 Lung Cancer Drug 71 Present Preclinical Data 71 Demonstrates Potential 71 Tumor Targeting 70 RNAi Therapeutics 70 Phase 2b Clinical Trial 70 Clinical Outcome 70 Synthetic Peptide 70 Aptamer 70 Initiates Clinical Trial 70 Novel Oral 70 Preclinical Data 70 Antiarrhythmic 70 Develop Novel 70 Epidermal Growth Factor Receptor 70 Antifungal 70 Breast Cancer Cells 70 siRNA Delivery 70 Renal Cancer 70 Aurora Kinase 69 Low Dose 69 Hematological Malignancies 69 Patients Treated With 69 Antitumor 69 Study Evaluating 69 Hsp# Inhibitor 69 Orally Active 69 Oncolytic 69 Mimetics 69 Anticancer Activity 69 Disease Modifying 69 Antigen Specific 69 Contrast Agents 69 Cannabinoid 69 Refractory Hodgkin Lymphoma 69 Atypical Antipsychotic 69 Shows Promise Against 69 Genes Involved 69 Demonstrates Potent 69 Potent Inhibitor 69 Improves Survival 69 Advanced Melanoma 69 Novel Antibiotic 69 Hormone Refractory Prostate Cancer 69 Diabetic Foot Ulcer 69 Anti Angiogenesis 68 Polymerase Inhibitor 68 Mouse Model 68 Monoclonal Antibody 68 Initiates Enrollment 68 Rheumatoid Arthritis Drug 68 Files IND 68 Novel Inhibitor 68 Advanced Colorectal Cancer 68 Aliskiren 68 Receptor Agonist 68 Inflammatory Arthritis 68 Inhibits 68 Fibrinogen 68 Survival Benefit 68 Smooth Muscle 68 Phase 2b Study 68 Demonstrates Positive 68 Investigational Compound 68 Shown Effective 68 Phase 2b Trial 68 Renal Cell Carcinoma 68 Dendritic Cells 68 Completes Patient Enrollment 68 Attenuates 68 Phase IIa Clinical Trial 68 Chemotherapeutic 68 Antitumor Activity 68 Demonstrates Efficacy 68 Thrombotic 68 Solid Tumor 68 Neuroprotective 68 Anticancer Agent 68 FDA Okays 68 Protease Inhibitor 68 Sustained Release 68 Oral Mucositis 68 Liposomal 68 Receives Orphan Drug Designation 68 Targeted Therapy 67 Novel Therapies 67 Protein Kinase 67 Molecular Mechanism 67 Prophylactic Treatment 67 Clinical Efficacy 67 Thrombolytic 67 Initiates Phase III 67 Antiviral Activity 67 Fungal Infections 67 Romidepsin 67 Teva Provides Update 67 Antithrombotic 67 IND Application 67 Breast Cancer Metastasis 67 Preclinical Study 67 Protein Expression 67 Oligonucleotides 67 Psoriasis Drug 67 Successfully Completes Phase 67 Reductase 67 Previously Treated 67 Investigational Treatment 67 Antiplatelet 67 Anti Inflammatory 67 Cell Adhesion 67 Anti angiogenic 67 Drug Shows Promise 67 Improved Survival 67 JAK Inhibitor 67 Inflammatory Diseases 67 Extracellular Matrix 67 Androgen Receptor 67 Modulates 67 Adjuvant Chemotherapy 67 Kidney Function 67 Tumor Growth 67 Therapeutic Vaccines 67 Shows Promising 67 Neuroprotection 67 Demonstrates Significant 67 Chemotherapy Improves 67 Anticoagulant 67 Immunostimulatory 67 Dose Finding 66 FDA Approvals 66 Adjuvant Treatment 66 Collaborators Present 66 Combination Treatment 66 Novel Small Molecule 66 Skeletal Muscle 66 Recombinant Human 66 Cardiotoxicity 66 bevacizumab Avastin R 66 Nicotine Vaccine 66 Transdermal Delivery 66 Highly Potent 66 Trial Evaluating 66 JAK2 Inhibitor 66 Metastatic Cancer 66 Receptor Antagonist 66 Oral Calcitonin 66 Leukemia Cells 66 Cytochrome P# 66 Signaling Pathways 66 Hemostatic 66 Significantly Improves 66 Potent Anti 66 Confirms Efficacy 66 Phase III Clinical Trial 66 Preclinical Models 66 Investigational Drug 66 Angiogenic 66 Radiation Induced 66 Oncolytic Reovirus 66 Tumor Necrosis Factor 66 Patient Enrollment 66 Bone Metastases 66 Inflammatory Disease 66 Fast Skeletal Troponin 66 Novel Anti Inflammatory 66 Sapacitabine 66 Autoimmune Disease 66 Interferon Gamma 66 Treated Patients 66 Milestone Payment 66 Potent Antiviral Activity 66 Male Contraceptive 66 Neoadjuvant Chemotherapy 66 Pharmacokinetic Study 66 See CLINICAL PHARMACOLOGY 66 Phase IIb Clinical Trial 66 Diabetic Nephropathy 66 HCV Protease Inhibitor 66 Myeloma Patients 66 Dehydrogenase 66 Vaccine Adjuvants 66 Drug Fails 66 Bortezomib 66 Prospective Randomized 66 Oral Fingolimod 66 Therapeutic Potential 66 Tyrosine Kinase 66 Prostate Cancer Vaccine 66 Soft Tissue Sarcoma 66 Radiofrequency Ablation 66 Gout Drug 66 Pharmacodynamics 66 Presents Positive 66 Pooled Analysis 66 Initiate Clinical Trial 66 Capecitabine 66 Generic Version 66 Anti CD# Antibody 66 Single Dose 66 Demonstrates Statistically Significant 66 Treating Chronic 66 Adjuvant Therapy 66 Anticancer Drugs 66 Protease Inhibitors 66 Cyclophosphamide 65 Breast Tumors 65 Transcription Factor 65 Metastatic Melanoma 65 Cyclooxygenase 2 65 Phase III Trial 65 Aflibercept 65 Blood Clotting 65 Pharmacodynamic 65 Immunosuppressive 65 Transdermal Patch 65 Investigational Oral 65 Patients Receiving 65 Dose Ranging Study 65 Study Demonstrates 65 Monoclonal Antibodies 65 Prodrug 65 Bosutinib 65 Recombinant Protein 65 Myelodysplastic Syndromes 65 Proteasome 65 Gastric Cancer 65 Anthracycline 65 Phase 2a Trial 65 PKC# 65 Receives Orphan Drug 65 Metabolic Disease 65 GW# [003] 65 Onyx Pharmaceuticals Announces 65 Commences Phase 65 Expanded Indication 65 Randomized Clinical Trial 65 Novel Compound 65 Vitro Activity 65 Fondaparinux 65 FDA Accepts 65 Embolic Protection 65 Nanoemulsion 65 Mucosal 65 BiTE Antibody 65 Autoimmune Diseases 65 Apoptotic 65 Histone Deacetylase 65 Cancer Cells 65 Angiotensin Converting Enzyme 65 Insulin Resistance 65 Demonstrates Sustained 65 Well Tolerated 65 Respiratory Virus 65 Significantly Improved 65 Chronic Hepatitis C 65 Dose Escalation 65 Adenoma 65 Tumor Suppressor 65 AnaSpec Introduces 65 Phase 2a Clinical Trial 65 Receptor Signaling 65 Gene Silencing 65 Antipsychotic 65 Phase IIb Trial 65 Estrogen Receptor 65 Licenses Novel 65 Anti Infective 65 Schizophrenia Treatment 65 Sirolimus Eluting Stent 65 Cholesterol Lowering Drug 65 Study Showed 65 Immune Responses 65 Cancer Stem Cells 65 Minimally Invasive Treatment 65 RNA Interference 65 Improves Outcomes 65 Oral Presentations 65 Initiate Phase 65 Taxane 65 Immunomedics Announces 65 Oligonucleotide 65 Investigational Agent 65 Contrast Agent 65 Blood Pressure Drug 65 Fulvestrant 65 Hematological Cancers 65 Analytical Tool 65 Mutagenesis 65 Neuroprotective Effects 65 Hepatitis C Infection 65 Receives Approvable Letter 65 Epilepsy Drug 65 Lupus Drug 65 Intravitreal 65 Lung Cancer Trial 65 Initiates Phase II 65 Chemotherapeutic Agents 64 Autologous Stem Cell Transplantation 64 Biocompatibility 64 Transcriptional 64 Selective Inhibitor 64 Receptor Antagonists 64 Patients Treated 64 Antibody Drug Conjugate 64 Fixed Dose 64 Pivotal Study 64 Ultrasound Contrast 64 Brain Metastases 64 Reduces Pain 64 Effectively Treats 64 Anti Phospholipid Therapy 64 Monoclonal 64 Gene Mutation 64 Mg Usa 64 Shows Statistically Significant 64 Meta Analysis 64 Mouse Models 64 Novel Protein 64 Patent Covering 64 Bevacizumab 64 Aneurysm Repair 64 Commence Phase 64 Molecular Pathogenesis 64 Interferon Alfa 64 Anthrax Toxin 64 Chronic Lymphocytic Leukemia 64 Potentially Fatal 64 Renal Cell Cancer 64 cetuximab Erbitux R 64 Unfractionated Heparin 64 Renal Impairment 64 Antisense Drug 64 Granted Orphan Drug 64 Anticancer Compound 64 Shows Efficacy 64 Biomarker Study 64 Randomized Phase 64 Lanthanum Carbonate 64 Crystallographic 64 Progenitor Cells 64 Interferon Beta 64 Dasatinib 64 Safinamide 64 Kidney Transplant Patients 64 Drug Eluting 64 Topical Treatment 64 Liver Injury 64 Relapsing Multiple Sclerosis 64 Clinical Trial Enrollment 64 Prospective Multicenter 64 Plasmid DNA 64 NMDA Receptor 64 Benign Prostatic Hyperplasia 64 Migraine Drug 64 Submits NDA 64 Targeted Therapies 64 Fluconazole 64 Assay Kits 64 Antisense 64 Severe Sepsis 64 First Patient Treated 64 Immune Cell 64 Pivotal Phase III 64 Inflammatory Markers 64 Retinoic Acid 64 Protein Synthesis 64 Long Term Efficacy 64 Lymphoid 64 Parathyroid Hormone 64 Gets FDA Clearance 64 Generic Versions 64 Malignant Melanoma 64 Osteoporosis Drug 64 Replacement Therapy 64 Anti VEGF 64 platform HDL Mimetic 64 Lung Cancers 64 Cytotoxicity 64 HDAC Inhibitor 64 Reports Preclinical Data 64 Non Invasive Treatment 64 Therapeutic Efficacy 64 IL# PE#QQR 64 Placebo Controlled Study 64 Virus Infection 64 Controlled Study 64 Daptomycin 64 Postdoctoral Position 64 fosbretabulin 64 Tumor Targeted 64 Tezampanel 64 Pegylated Liposomal Doxorubicin 64 HER2 Positive 64 Tumor Cell 64 NDA Submission 64 Disease Progression 64 Anti Inflammatory Drug 64 Solid Tumors 64 Muscarinic 64 Showed Significant 64 Safety Tolerability 64 Antidiabetic 64 Previously Untreated 64 Anti Inflammatory Drugs 64 Prognostic Factors 64 Phase III Trials 64 Monotherapy 64 Biomolecules 64 Cancer Vaccines 64 FDA Clears 64 Inhibitory 64 Fluorouracil 64 Refractory Angina 64 Seasonal Influenza Vaccine 64 Structure Function 64 Neovascularization 64 Dose Response 64 Cardiac Function 64 Embolic 64 Glycosylation 64 Gene Expression Analysis 64 CHMP Opinion 64 Initiates Phase 2b 64 Malignant Glioma 64 Statistically Significant 64 Antiviral Therapy 64 Tumor Response 64 Drug Resistant 64 Protein Kinase C 64 Hypertensive Patients 63 Wound Dressings 63 Peginterferon 63 Pertuzumab 63 Gastrointestinal Disorders 63 Multiple Myeloma Patients 63 Molecular Diagnostic 63 Improve Survival 63 R lenalidomide 63 Single Molecule 63 Efficacy Trial 63 Clinical Trial Data 63 Combination Therapy 63 Diabetic Neuropathy 63 Tablet Formulation 63 erlotinib Tarceva ® 63 Erythropoietic 63 Phase 1b Clinical Trial 63 Cinacalcet 63 Factor Receptor 63 Cholesterol Drug 63 Announces FDA Clearance 63 Immunosuppression 63 Neural Stem Cell 63 Enlarged Prostate 63 Mycophenolate Mofetil 63 Placebo Controlled Trial 63 Receives FDA Clearance 63 Intracellular 63 Diagnostic Tests 63 Completes Enrollment 63 Crit Rev 63 Protein Linked 63 Initiate Phase III 63 Milestone Payment From 63 Drug Combo 63 Metastatic Colorectal Cancer 63 Secretory 63 Viral Infections 63 Intravesical 63 Receives Milestone Payment 63 Metabolic Disorder 63 Earns Milestone Payment 63 Neoadjuvant 63 Susceptibility Testing 63 sunitinib Sutent ® 63 Hematologic Malignancies 63 Phase Ib Clinical Trial 63 Postmenopausal Osteoporosis 63 Controlled Clinical Trial 63 Osteoporosis Treatment 63 Cancer Treatments 63 Lung Cancer Survival 63 Incretin 63 Advanced Renal Cell 63 Randomized Double blind 63 Anemia Drug 63 Novel Vaccine 63 Slows Progression 63 Treatment Reduces 63 Omacetaxine 63 Cell Transplants 63 Novel Therapeutics 63 Azacitidine 63 Signaling Pathway 63 Treatment Regimen 63 Antibody Discovery 63 Myocardial Ischemia 63 Sustained Efficacy 63 Lung Tumors 63 Epithelial Cell 63 Adjuvant 63 Hypercholesterolemia 63 Multicenter Study 63 Secondary Hyperparathyroidism 63 TNF Alpha 63 Therapeutic Antibodies 63 Chemotherapy Induced 63 Vaccine Adjuvant 63 Photodynamic Therapy 63 Radioimmunotherapy 63 Double Blind Placebo 63 Ion Channels 63 Fracture Risk 63 Cocaine Addiction 63 Molecular Mechanisms 63 Multicenter Trial 63 entitled Compositions 63 Randomized Study 63 Companion Diagnostic 63 Nuclear Receptors 63 Myelodysplastic Syndrome MDS 63 Irinotecan 63 Initiates Dosing 63 5 Fluorouracil 63 Prove Effective 63 Clinical Evaluation 63 Whole Genome Sequencing 63 Lentiviral 63 Castration Resistant Prostate Cancer 63 Peginterferon Alfa 2a 63 Proven Effective 63 Breast Cancer Stem Cells 63 Complicated Skin 63 Desvenlafaxine Succinate 63 Initiates Phase 63 Novel Method 63 Chemoradiation 63 Metastatic Renal Cell Carcinoma 63 Study Shows Benefits 63 Pivotal Trial 63 Blinatumomab 63 Develops Novel 63 Sipuleucel T 63 Intravascular 63 Dose Escalation Study 63 Nucleic Acids 63 Controlled Trial 63 Multicenter Randomized 63 Randomized Double Blind Placebo 63 Breast Cancer Recurrence 63 Pegylated 63 Anti Diabetic 63 Medoxomil 63 Clinical Trial Evaluating 63 Regenerative Cells 63 HER2 Positive Breast Cancer 63 Antithrombin 63 Analgesic 63 Nucleic Acid 63 Combo Therapy 63 Excretion 63 Image Guided 63 Fewer Side Effects 63 Drug Metabolism 63 Endothelial Cells 63 Tesamorelin 63 Denufosol 63 Adjunctive Therapy 63 Genetic Variation 63 Gene Variation 63 Pharmaceuticals Initiates 63 Hedgehog Pathway Inhibitor 63 Newly Diagnosed Multiple Myeloma 63 Reduced Risk 63 Camptosar ® irinotecan 63 Oral Cavity 62 Interferon Alpha 62 J Clin 62 Combination REOLYSIN R 62 Corticosteroid 62 Statin Therapy 62 Hematological 62 Therapeutic Competitors Companies 62 Protein Kinase Inhibitors 62 Therapeutic Vaccine 62 Patient Treated 62 Leukocyte 62 Antigens 62 Allosteric 62 Non Invasive 62 Melphalan 62 Initiates Clinical Trials 62 Conjugated 62 Protein Interaction 62 Demonstrates Ability 62 Gene Variants 62 Severe Asthma 62 Advanced Prostate Cancer 62 Beneficial Effects 62 Fludarabine 62 Oxidase 62 Cell Proliferation 62 Muscle Wasting 62 Prostate Cancer Treatment 62 Kahalalide F 62 Ridaforolimus 62 First Patient Dosed 62 Blood Pressure Lowering 62 Posaconazole 62 Naive Patients 62 Analogs 62 Hematopoietic 62 Preclinical Evaluation 62 Randomized Double Blind 62 Test Detects 62 Knee Osteoarthritis 62 Antimalarial 62 Double Blind Randomized 62 Tubulin 62 Renal Anemia 62 Nano Scale 62 Lowers Risk 62 Nilotinib 62 Diffuse Large B 62 Bucindolol 62 Lyophilized 62 Preclinical Development 62 Dosage Forms 62 Combination Clinical Trial 62 Decitabine 62 Cutaneous T 62 Pharmacological 62 Pharmacologic 62 Hepatitis C Virus 62 Confirmatory Phase 62 Impotence Drug 62 Novel Treatments 62 Kidney Transplant Recipients 62 Advanced Pancreatic Cancer 62 Newly Diagnosed 62 Embolization 62 Drug Prevents 62 Naturally Occurring 62 Anticancer 62 Phase III Clinical Trials 62 Cancer Therapies 62 Stent Restenosis 62 Novel Antibody 62 Genetic Mutation 62 Immunogenic 62 Septic Shock 62 Pharmacokinetics PK 62 Relapsed Refractory 62 Files Investigational 62 Homeostasis 62 Protein Involved 62 Progenitor Cell 62 Suppresses 62 Appears Safe 62 Immune Cells 62 Enzyme Replacement Therapy 62 Ligands 62 Nucleotide 62 Therapy Improves 62 Neuroendocrine Tumors 62 Immune Therapy 62 Macromolecular 62 Cardiac Rhythm 62 AVI BioPharma Announces 62 Inhaled Nitric Oxide 62 Tumor Suppressor Gene 62 Antibacterials 62 Advanced Ovarian Cancer 62 Artery Disease 62 Circulating Tumor Cells 62 Molecular Basis 62 Oral Anticoagulant 62 Novel Peptide 62 Increased Mortality 62 Pulmonary Arterial Hypertension 62 Pivotal Phase 62 Randomized Trials 62 Telaprevir VX 62 Inhaled Corticosteroids 62 Resistant Hypertension 62 Cancer Immunotherapy 62 FDA Clearance 62 Eculizumab 62 Lung Infections 62 Plaque Psoriasis 62 Predict Response 62 Liver Tumors 62 Neurogenic 62 familial amyloidotic polyneuropathy FAP 62 Bisphosphonate 62 Companion Diagnostics 62 Thyroid Hormone 62 Intravenous Formulation 62 Late Breaker 62 Preclinical Testing 62 dasatinib Sprycel 62 Menstrual Pain 62 Inflammatory Response 62 Resubmission 62 Induces 62 Blood Cancers 62 Antidepressant Drug 62 Gene Variant 62 Risk Stratification 62 Schizophrenia Drug 62 Tigecycline 62 Atopic Dermatitis 62 Treat Anemia 62 Renal Function 62 Abstract Accepted 62 Nymox NX 62 ARRY # 62 Cervical Dysplasia 62 Histone 62 Binding Protein 62 Polymorphisms 62 Allergic Rhinitis 62 apoptosis inducing 62 IND Filing 62 Collaborators Publish 62 Blood Thinner 62 Patients Undergoing 62 Avian Flu Vaccine 62 Allogeneic 62 Trodusquemine MSI 62 Anticonvulsant 62 Rheumatoid Arthritis Patients 62 Endocrinol 62 Eluting Stent 62 Faropenem 62 Insulin Glargine 62 Phospholipase 62 Conjugates 62 Uric Acid 62 Vascular Targeting Agents 62 Renal Artery 62 Left Ventricular 62 Tumor Progression 62 Malaria Vaccine 62 Bacterial Infection 62 Avian Influenza Vaccine 62 Recurrent Breast Cancer 62 Malignant Pleural Mesothelioma 62 Prognostic Significance 62 Minimally Invasive Procedure 62 Hepatocellular 62 Stent Coating 62 Shows Promise 62 Molecular Diagnostic Test 62 Polymerase 62 Tissue Engineered 62 Ultrasensitive 62 Chronic Myeloid Leukemia 62 Colorectal Cancer Patients 61 Skin Lesions 61 gefitinib Iressa 61 Bivalirudin 61 Atypical Hemolytic Uremic Syndrome 61 Cell Signaling 61 Therapeutic Competitors Report 61 Oral Insulin 61 Is Well Tolerated 61 Pivotal Trials 61 Fast Track Status 61 Neurol 61 Treatment Naïve 61 Erectile Dysfunction Drug 61 Prognostic Value 61 Data Suggest 61 Adverse Event 61 small molecule tyrosine 61 Mesothelioma Treatment 61 Transthyretin 61 Occlusion 61 Metastatic Prostate Cancer 61 Gene Linked 61 FDA Approvable Letter 61 Anti Fungal 61 Hospital Acquired Pneumonia 61 Lenalidomide 61 Inhibitor 61 Antiepileptic Drug 61 Ovarian Cancers 61 Coronary Arteries 61 Lipid Lowering 61 Oxidative Stress 61 thalidomide Thalomid 61 Hepatocellular Carcinoma 61 Xelox 61 Motility 61 Proves Effective 61 Contrast Enhanced 61 Myocardial Perfusion Imaging 61 Protease 61 Antibody 61 Neovascular Age Related Macular 61 Cardiomyocytes 61 Imaging Techniques 61 Polymorphism 61 Vaccine Candidate 61 Autoantibodies 61 Blood Thinning 61 Therapeutic Agents 61 Artificial Pancreas 61 Invasive Fungal Infections 61 Transfection 61 Announces Tentative Approval 61 Microfluidic Devices 61 Hematopoietic Stem Cell Transplantation 61 Beta Blocker 61 Fluticasone 61 Tipranavir 61 Endometrial Cancer 61 Progressive Multifocal Leukoencephalopathy 61 Cancer AACR NCI 61 ISTODAX ® 61 Therapy Reduces 61 II Clinical Trial 61 REMINDER ORLive Presents 61 Arterial Disease 61 Antipsychotic Drug 61 Initiated Phase 61 Lamotrigine 61 Endometrial 61 Potency 61 pralatrexate injection folate analogue 61 Slow Progression 61 Phosphorylation 61 Enzastaurin 61 Antisense Oligonucleotides 61 Immune Mediated 61 Somatostatin 61 Pediatric Patients 61 Tumor Microenvironment 61 Dual Antiplatelet Therapy 61 Valsartan 61 Antihypertensive 61 antifibrotic 61 Pre Cancerous 61 Pivotal Phase II 61 Cardiovascular Mortality 61 Osteoporosis Drugs 61 Antiviral 61 Pain Therapy 61 Innate Immunity 61 Ischemic 61 Ultrasound Imaging 61 Diastolic Heart Failure 61 Cardiovascular Disease Risk 61 Antitumor activity 61 Cancer Vaccine 61 Eukaryotic 61 Itraconazole 61 Cardiovasc 61 Ozarelix 61 Breast Tumor 61 Demonstrate Significant 61 Abuse Resistant 61 Migraine Treatment 61 Further Validates 61 Adenoviral 61 Platelet Aggregation 61 Bioavailability 61 Molecular Evolution 61 Tissue Repair 61 Stent Thrombosis 61 CCX# B 61 Maleate 61 Anti infective 61 Patents Covering 61 Venous Thromboembolism 61 Pemetrexed 61 Inhaled Liposomal Ciprofloxacin 61 Plus Ribavirin 61 Prodrugs 61 Patients Enrolled 61 Trastuzumab DM1 61 Acute Ischemic Stroke 61 Lupus Nephritis 61 Universal Flu Vaccine 61 Rotavirus Vaccine 61 Oncogenic 61 Treatment Naive Patients 61 Boceprevir 61 Suicidality 61 Extended Release 61 Placebo Controlled 61 ORLive Presents 61 Hepatic Encephalopathy 61 Chemokine Receptor 61 Autoimmune Disorders 61 Breast Cancers 61 bevacizumab Avastin ® 61 Efficacious 61 Human Neural Stem 61 Protein Therapeutics 61 Unresectable 61 Bazedoxifene 61 Oncol 61 Antiviral Drugs 61 Chronic Sinusitis 61 Hormonal Therapy 61 Randomized Clinical Trials 61 Entry Inhibitor 61 AASLD Meeting 61 Retroviral 61 Helps Identify 61 Quantitation 61 Long Term Survival 61 Nebulized 61 Conjugate 61 Antiviral Agents 61 Heart Failure Patients 61 Intracerebral Hemorrhage 61 Nicotinic 61 Carotid Stenting 61 Lung Cancer Patients 61 PDUFA Date 61 Synthase 61 adalimumab Humira 61 Hormone Receptor Positive 61 Chimeric 61 Bioartificial Liver 60 Radiopharmaceutical 60 Chemoprevention 60 Novel Compounds 60 Cell Differentiation 60 Epithelial 60 Myelodysplastic Syndrome 60 Romiplostim 60 Clin Oncol 60 Inactivation 60 Pathogenesis 60 Critically Ill Patients 60 Glufosfamide 60 Endovascular Treatment 60 Liver Failure 60 Reduces Mortality 60 Announces Initiation 60 Stomach Cancer 60 Randomized Phase II 60 Newly Identified 60 Detect Cancer 60 vinorelbine tartrate 60 imatinib Gleevec ® 60 Tumor Angiogenesis 60 Cellular Immunotherapy 60 Inflammatory Pain 60 Magnetic Nanoparticles 60 Clostridium difficile Infection 60 Liver Toxicity 60 Genes Linked 60 Cloretazine ® 60 Urinary Incontinence 60 Xenograft 60 Eluting 60 Achieves Primary Endpoint 60 Voreloxin 60 Nerve Regeneration 60 Asthma Treatment 60 Levels Linked 60 Interv 60 potent suppressor 60 Bicalutamide 60 Differentially 60 Anti Infectives 60 Experimental Vaccine 60 Stem Cell Differentiation 60 Protein Structures 60 Eribulin 60 Cancer Therapeutic 60 Breast Tissue